前列腺特异性膜抗原局灶消融影像评分(PSMA-FAB)
本文提出一种基于PSMA PET/CT的局灶消融后影像评分系统PSMA-FAB,分为1-3级指导后续管理。同时建议将PI-FAB与PSMA-FAB整合为FIRE-SCORE用于随访决策。
要点
- PSMA-FAB 1级建议继续监测。
- PSMA-FAB 2级需评估PSA动力学和MRI,可疑时考虑活检。
- PSMA-FAB 3级推荐活检。
核心结论
- 提出PSMA-FAB评分系统用于前列腺癌局灶治疗后PSMA PET/CT影像评估。
- 建议整合PI-FAB与PSMA-FAB为FIRE-SCORE辅助随访管理。
主要发现
- PSMA-FAB基于治疗前和治疗后影像分为1、2、3级。
- PSMA-FAB 1级对应继续监测。
- PSMA-FAB 2级需评估PSA动力学和MRI,可疑时考虑活检。
- PSMA-FAB 3级推荐活检。
关键数值与推荐
- PSMA-FAB 1:继续监测。
- PSMA-FAB 2:评估PSA动力学和MRI,可疑时考虑活检。
- PSMA-FAB 3:推荐活检。
临床怎么用
- 利用PSMA-FAB评分对局灶治疗后患者进行风险分层并指导活检决策。
- 结合PI-FAB与PSMA-FAB的FIRE-SCORE可用于随访管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Prostate Imaging after Focal Ablation (PI-FAB) score has been recently proposed for scoring the appearance on multiparametric magnetic resonance imaging (mpMRI) of prostate cancer after focal therapy. The progressive implementation of prostate specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) into the management of prostate cancer has revolutionized the diagnostic work-up and inspired our proposal for a dedicated PSMA Focal Ablation Imaging (PSMA-FAB) scoring system. Based on pre- and post-treatment imaging, the classification is categorized into: PSMA-FAB 1 (continue monitoring); PSMA-FAB2 (assess PSA kinetics and MRI, with biopsy to be considered in case of suspicion); and PSMA-FAB 3 (recommend biopsy). Furthermore, a combined Focal-therapy Imaging Response Evaluation Score (FIRE-SCORE) embedding PI-FAB and PSMA-FAB scores is suggested to help patient's management at follow up.
引用
- Lopci E, Lazzeri M, Fasulo V, et al. Prostate specific membrane antigen focal ablation imaging (PSMA-FAB). Prostate Cancer Prostatic Dis. 2025. PMID: 40738964. doi:10.1038/s41391-025-01005-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。